Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2002
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002WO2002077199A2 Methods and products related to fgf dimerization
10/03/2002WO2002077174A2 Human cytokine receptor
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076990A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076968A1 Malonates as inhibitors of the ice/ced-6 family of cysteine proteases
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076508A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076504A1 Remedies for inflammatory bowel diseases
10/03/2002WO2002076493A1 Novel drugs for preventing/treating immunopathic diseases
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076483A2 Bacteriophage preparation
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076443A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076435A2 Lipid profile modulation with steroids
10/03/2002WO2002076434A2 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/03/2002WO2002076398A2 Improved forms of pharmaceutically active agents and method for manufacture thereof
10/03/2002WO2002076381A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002076173A2 Inhibitors of glycosaminoglycans
10/03/2002WO2002062794A3 Compounds
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002062293A3 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002022657A3 Peptide antagonist of multiple chemokine receptors and uses thereof
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001017508A9 Cationic liposome delivery of taxanes to angiogenic blood vessels
10/03/2002WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143069 For therapy of polymorphoneutrophil (PMN) inflammation
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143035 Hydantoin compounds useful as anti-inflammatory agents
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143028 For therapy of pain
10/03/2002US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002US20020143004 Allosteric adenosine receptor modulators
10/03/2002US20020142996 Use of bisphosphonic acids for treating angiogenesis
10/03/2002US20020142991 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142962 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
10/03/2002US20020142943 A drug and an agent capable of inducing the dephosphorylation of phosphorylated serine and/or threonine residue of p100 and/or p120, wherein the ability of the drug to cross a physiological barrier is improved.
10/03/2002US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142283 Inhibitors of C-reactive protein induced inflammation
10/03/2002US20020142083 Process for the production of tocotrienols
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142029 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments
10/03/2002US20020142025 Mixture of proteins, carbohydrates, methionine, cysteine, folic acid, pyridoxal and zinc
10/03/2002US20020142012 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141971 Administering by tissue absorption
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441986A1 Methods and products related to fgf dimerization
10/03/2002CA2441933A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2439409A1 Inhibitors of glycosaminoglycans
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2410469A1 Improved forms of pharmaceutically active agents and method for manufacture thereof
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 1272